Cullinan Therapeutics, Inc.
Cullinan Therapeutics, Inc. (CGEM) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CGEM · as of Jun 8, 2026
Key Statistics
Explore Cullinan Therapeutics, Inc. Data
cgem stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 8 · Buy rate: 100.0%
The CGEM analyst consensus is Buy, based on ratings from 8 Wall Street analysts over the past 3 months. The average 12-month price target is $31.00, representing +129.46% upside from the current price of $13.51.
Competitors & Peers
cgem competitorsCGEM
ADCT
BCYC
CBLL
EHAB
LABStock Performance
Full HistoryAbout Cullinan Therapeutics, Inc.
Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the developing of oncology and immuno-oncology therapies. Its pipeline includes CLN-978, CLN-619, Zipalertin…
what is cullinan therapeutics, inc. · cgem stock overview · cullinan therapeutics, inc. company profile · who is cullinan therapeutics, inc. ceo · cgem NASDAQ · cullinan therapeutics, inc. headquarters · cullinan therapeutics, inc. business segments
About Stock Overview & Key Data
Cullinan Therapeutics, Inc. (CGEM) is a Healthcare company in the Medical - Pharmaceuticals industry, listed on NASDAQ since Jan 8, 2021. As of the latest trading session, CGEM stock price is $13.51, with a market capitalization of $818.8M. The stock has returned +52.09% over the past 12 months and +28.72% year-to-date.
According to 8 Wall Street analysts, the consensus rating for Cullinan Therapeutics, Inc. stock is Buy, with an average 12-month price target of $31.00. In fiscal year 2025, Cullinan Therapeutics, Inc. reported revenue of — and net income of -$219.9M. For detailed data — including Cullinan Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Cullinan Therapeutics, Inc. (CGEM) stock price is $13.51. The stock is traded on NASDAQ under the ticker symbol CGEM. The 52-week range is $5.68 – $16.74.